Status:
COMPLETED
Improving BP Control in Diverse Populations Using BP MAP
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
OCHIN, Inc.
Louisiana Public Health Institute
Conditions:
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilit...
Detailed Description
BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilit...
Eligibility Criteria
Inclusion
- ACTIVE CLINICS
- For inclusion as an Active Clinic in this study, clinics may participate must be able to identify:
- A Site Champion who works at the clinic and who is willing to take primary responsibility for implementing the M.A.P. intervention
- A Physician Champion who works at the clinic and who is willing to advocate actively for the M.A.P. intervention
- A Practice Change Facilitator willing to attend a 1-day training and help guide implementation of the M.A.P intervention for Full Support sites, with the support of AMA staff (may be the Site Champion or Physician Champion, or a person with regional responsibilities who can support multiple sites)
- Sites will be excluded if they:
- Have implemented any high blood pressure quality improvement component from the M.A.P. BP improvement program as part of Target: BP or from the AMA or Target: BP websites
- Are currently involved in an ongoing clinical trial or grant funded project related to high blood pressure or hypertension
- USUAL CARE CLINICS:
- Usual Care Clinics will include PCORnet Datamarts participating in BP TRACK, a concurrently-running BP Control Registry within PCORnet that will provide quarterly datamart-level estimates of BP control and other aggregate metrics relevant to BP control. All participating datamarts will be included, with the following exceptions:
- Datamarts with any Active Clinics participating in BP MAP will be excluded
- Datamarts that obscure dates via date-shifting will be excluded, as this will not allow for control of concurrent secular trends
- PATIENTS
- Within clinics (Active or Usual Care), patients will be eligible (and identified from the electronic health record) if they meet National Quality Forum BP Control Metric (NQF 0018) criteria:
- Age 18-85 on the date of analysis
- At least one outpatient encounter with a diagnosis of hypertension during the first six months of the measurement year (ending on the date of analysis)
- No diagnosis or evidence of end-stage renal disease on or prior to the end of the measurement year
- No pregnancy during the measurement year
- No admission to an inpatient setting during the measurement year
Exclusion
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
1238835 Patients enrolled
Trial Details
Trial ID
NCT03818659
Start Date
July 1 2019
End Date
June 30 2021
Last Update
March 3 2025
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Open Door Del Norte CHC
Crescent City, California, United States, 95531
2
Open Door Eureka Community Health & Wellness Center
Eureka, California, United States, 95501
3
QueensCare Echo Park Clinic
Los Angeles, California, United States, 90026
4
Monterey County Health Department Laurel Family Practice
Salinas, California, United States, 93906